Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stock Charts To Watch: AUPH, EIDX, KERN, LSCC, SWAV

Published 12/12/2019, 12:37 AM
Updated 07/09/2023, 06:31 AM

  • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) exploded on news a week ago, pulled back for a day, and is now ramping up. I love the look of this stock. On Wednesday, it was up 76 cents, or 4.29%, to 18.46, and closing pennies of the high at 18.49, on 7.6 million shares. At this point, with this stock making a new high on Wednesday, I’m looking for an immediate run to 22.

  • Eidos Therapeutics , Inc. (NASDAQ:EIDX) swing worked beautifully as it popped, I gave you a swing on it at the 54-55 range, and has moved up more than 10-points to the good on Wednesday, jumping 5.45, or 9%, to 65.60, reaching the session and 52-week high of 65.63, on 158,126 shares traded. The next targets for this stock are 67 and 75. The top-of-the-channel target might be up around 80.

  • Akerna (NASDAQ:KERN) has been consolidating for a week, popping 40 cents, or 3.45%, to 12.00, with a high of 12.73, on 228,033 shares traded on Wednesday. It looks to me like, with that trend, momentum, and volume, this stock is going to be headed for, I think, the 20-21 range going forward.

  • Lattice Semiconductor Corporation (NASDAQ:LSCC), one of my old swings, popped out of a flag on Wednesday and gained 77 cents, or 4.09%, to 19.60, with a high of 19.91, on 1.36 million shares. It needs to get over the double/triple top around the 21 1/4 range. If it gets through that, we’re looking at 26 and 31 as targets.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

  • ShockWave Medical, Inc. (NASDAQ:SWAV) swing is slow but steady on its way up, each day reaching just a little higher. On Wednesday, it popped 1.39, or 3.44%, to 41.81, reaching a high of 41.96, on 524,519 shares traded. This is the highest level achieved since the breakdown back in Aug. The next target is going to be a run and a test of 44-44 1/2.

Stocks on the long side included Abeona Therapeutics Inc. (ABEO), Aptose Biosciences Inc. (APTO), Aurinia Pharmaceuticals Inc. (AUPH), Avid Bioservices, Inc. (CDMO), CryoLife, Inc. (CRY), Dermira, Inc. (DERM), Eidos Therapeutics, Inc. (EIDX), Jounce Therapeutics, Inc. (JNCE), Akerna (KERN), Eastman Kodak Company (KODK), Lands' End, Inc. (LE), LMP Automotive Holdings, Inc. (LMPX), Lattice Semiconductor Corporation (LSCC), Livent Corporation (LTHM), Ollie's Bargain Outlet Holdings, Inc. (OLLI), Photronics, Inc. (PLAB), Proteostasis Therapeutics, Inc. (PTI), Sibanye Gold Limited (SBGL), Sorrento Therapeutics, Inc. (SRNE), and ShockWave Medical, Inc. (SWAV).

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.